Objective
Cytokines form a family of specialized proteins that mediate communication between immune cell-types. They play a central role in the initiation and regulation of the immune response. Thymic stromal lymphopoietin (TSLP) is a recently discovered cytokine and thus constitutes an emerging area of research in immunology. We were the first to describe the function of this novel cytokine. Human TSLP is produced by epithelial, stromal and mast cells. It functions by activating myeloid CD11c+ dendritic cells, which subsequently modulate the T cell immune response. Although there is a strong functional and pathological link between human TSLP and allergy, preliminary data show that TSLP is produced in other types of inflammation. Besides our early work, the biology and disease association of human TSLP remain largely unknown.
The objective of this proposal is to study the role of human TSLP in the immune system and in the pathophysiology of immune-related diseases using three different approaches:
1) Study of TSLP-activated CD11c+ dendritic cells and their interaction with T cells, B cells and NK cells;
2) molecular characterization of TSLP function using large-scale transcriptional analysis of TSLP-activated cells, and study of selected TSLP-induced genes in terms of expression profile, regulation and function;
3) Assessment of the in situ production of TSLP by immuno-histology in a broad array of diseases.
Our research project should help identify new cellular and molecular pathways regulating immune responses. The in situ study of TSLP could shed new light in the pathophysiology of immune-related diseases such as allergy, infectious diseases and cancer. TSLP and/or TSLP-induced molecules could serve as diagnostic/prognostic markers or constitute new therapeutic targets. The constitution of a European pole of excellence in the study of human TSLP will increase the attractiveness and competitiveness of European research in immunology and related fields.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine physiology pathophysiology
- medical and health sciences basic medicine immunology
- medical and health sciences clinical medicine allergology
- medical and health sciences clinical medicine oncology cervical cancer
- medical and health sciences health sciences infectious diseases DNA viruses
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-8
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.